Assessment of the validity of the clinical pathway for colon endoscopic submucosal dissection

Table 1 Results of the patients reviewed

	Group A	Group B	Total or average
Number	156	33	189
Average hospitalization period (d)	4.94	6.67	5.81
Location of lesion
Colon (%)	108 (69.2)	23 (70.0)	131 (69.0)
Rectum (%)	48 (30.8)	10 (30.3)	58 (31)
Median size of lesion (mm)	34.5	35	35
Hemorrhage (%)	1 (0.6)	4 (12.1)	5 (2.6)
Perforation (%)	1 (0.6)	6 (18.2)	7 (3.7)
Abdominal pain (%)	2 (1.3)	5 (15.2)	7 (3.7)
Fever > 38.0  °C (%)	2 (1.3)	2 (6.1)	4 (2.1)
WBC (cells/μL; median)	6800a	7700	7000
Hemoglobin level change pre-/post-ESD > 2.0 (%)	5 (3.2)	1 (3.0)	6 (3.2)
CRP (mg/dL; mean)	0.4b	0.5	0.4

^aP = 0.023,

^bP = 0.54 vs group B. ESD: Endoscopic submucosal dissection; CRP: C-reactive protein; WBC: White blood cell.